These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27821276)

  • 1. Antibody recognition of aberrant glycosylation on the surface of cancer cells.
    Soliman C; Yuriev E; Ramsland PA
    Curr Opin Struct Biol; 2017 Jun; 44():1-8. PubMed ID: 27821276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer.
    Cornelissen LA; Van Vliet SJ
    Biomolecules; 2016 May; 6(2):. PubMed ID: 27153100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural biology of antibody recognition of carbohydrate epitopes and potential uses for targeted cancer immunotherapies.
    Dingjan T; Spendlove I; Durrant LG; Scott AM; Yuriev E; Ramsland PA
    Mol Immunol; 2015 Oct; 67(2 Pt A):75-88. PubMed ID: 25757815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody recognition of carbohydrate epitopes†.
    Haji-Ghassemi O; Blackler RJ; Martin Young N; Evans SV
    Glycobiology; 2015 Sep; 25(9):920-52. PubMed ID: 26033938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycans in immune recognition and response.
    Amon R; Reuven EM; Leviatan Ben-Arye S; Padler-Karavani V
    Carbohydr Res; 2014 May; 389():115-22. PubMed ID: 24680512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and immunological characterization of the N-glycans from the major yellow jacket allergen Ves v 2: the N-glycan structures are needed for the human antibody recognition.
    Seppälä U; Selby D; Monsalve R; King TP; Ebner C; Roepstorff P; Bohle B
    Mol Immunol; 2009 Jun; 46(10):2014-21. PubMed ID: 19375166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140.
    Go EP; Herschhorn A; Gu C; Castillo-Menendez L; Zhang S; Mao Y; Chen H; Ding H; Wakefield JK; Hua D; Liao HX; Kappes JC; Sodroski J; Desaire H
    J Virol; 2015 Aug; 89(16):8245-57. PubMed ID: 26018173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface glycan-lectin interactions in tumor metastasis.
    Rambaruth ND; Dwek MV
    Acta Histochem; 2011 Oct; 113(6):591-600. PubMed ID: 21501858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.
    Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK
    J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycans from avian influenza virus are recognized by chicken dendritic cells and are targets for the humoral immune response in chicken.
    de Geus ED; Tefsen B; van Haarlem DA; van Eden W; van Die I; Vervelde L
    Mol Immunol; 2013 Dec; 56(4):452-62. PubMed ID: 23911401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate dynamics: Antibody glycans wiggle and jiggle.
    Meier S; Duus J
    Nat Chem Biol; 2011 Mar; 7(3):131-2. PubMed ID: 21321549
    [No Abstract]   [Full Text] [Related]  

  • 12. Roles of glycans in interactions between gp120 and HIV broadly neutralizing antibodies.
    Qi Y; Jo S; Im W
    Glycobiology; 2016 Mar; 26(3):251-60. PubMed ID: 26537503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple sugars to complex disease--mucin-type O-glycans in cancer.
    Kudelka MR; Ju T; Heimburg-Molinaro J; Cummings RD
    Adv Cancer Res; 2015; 126():53-135. PubMed ID: 25727146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications.
    Tikhonov A; Smoldovskaya O; Feyzkhanova G; Kushlinskii N; Rubina A
    Clin Chem Lab Med; 2020 Sep; 58(10):1611-1622. PubMed ID: 32324152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A recombinant fungal lectin for labeling truncated glycans on human cancer cells.
    Audfray A; Beldjoudi M; Breiman A; Hurbin A; Boos I; Unverzagt C; Bouras M; Lantuejoul S; Coll JL; Varrot A; Le Pendu J; Busser B; Imberty A
    PLoS One; 2015; 10(6):e0128190. PubMed ID: 26042789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathobiological implications of mucin glycans in cancer: Sweet poison and novel targets.
    Chugh S; Gnanapragassam VS; Jain M; Rachagani S; Ponnusamy MP; Batra SK
    Biochim Biophys Acta; 2015 Dec; 1856(2):211-25. PubMed ID: 26318196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of altered glycoprotein-bound N- and O-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells.
    Lange T; Samatov TR; Tonevitsky AG; Schumacher U
    Carbohydr Res; 2014 May; 389():39-45. PubMed ID: 24491280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical remodeling cell surface glycans for immunotargeting of tumor cells.
    Li X; Xu X; Rao X; Tian Y; Yi W
    Carbohydr Res; 2017 Nov; 452():25-34. PubMed ID: 29035749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosylation in cancer: mechanisms and clinical implications.
    Pinho SS; Reis CA
    Nat Rev Cancer; 2015 Sep; 15(9):540-55. PubMed ID: 26289314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies from Lampreys as Smart Anti-Glycan Reagents (SAGRs): Perspectives on Their Specificity, Structure, and Glyco-genomics.
    McKitrick TR; Eris D; Mondal N; Aryal RP; McCurley N; Heimburg-Molinaro J; Cummings RD
    Biochemistry; 2020 Sep; 59(34):3111-3122. PubMed ID: 32052624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.